US Patent Issued to Gencellmed on May 19 for "Recombinant herpes simplex virus for multiple targeting and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,399, issued on May 19, was assigned to Gencellmed Inc. (Seoul, South Korea).

"Recombinant herpes simplex virus for multiple targeting and use thereof" was invented by Heechung Kwon (Gyeonggi-do, South Korea) and Hyunjung Baek (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Proposed are a recombinant herpes simplex virus for multiple targeting and the use thereof. Particularly, a recombinant HSV capable of multiple targeting through multiple expression of an adapter, which is a fused protein of a cancer-cell-targeting domain and an extracellular domain of HVEM, a recombinant HSV capable of multiple targeting by having a modifi...